AFT Pharmaceuticals, Ltd.
Quick facts
Phase 3 pipeline
- Combogesic® tablets · Pain Management
Combogesic combines paracetamol and ibuprofen to provide analgesic and anti-inflammatory pain relief through dual inhibition of prostaglandin synthesis and central pain pathways. - Maxigesic IV · Pain Management
Maxigesic IV combines paracetamol and ibuprofen to provide analgesia and anti-inflammation through dual inhibition of prostaglandin synthesis and central pain modulation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: